The absence of Regnase-1 reprograms CD8+ T cells to increase their inflammatory activity and persistence, thereby enhancing control of solid tumors [230], and co-knockout with Roquin-1 can significantly improve this anti-tumor function [231]. This evidence concerns the gene CD8A and neoplasm.